Arbutus Biopharma Corp
NASDAQ:ABUS
Arbutus Biopharma Corp
NASDAQ:ABUS
Price:
5.065
USD
-0.1%
Market Closed
Market Cap:
$1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
US |
|
D
|
DR Horton Inc
XMUN:HO2
|
US |
|
Applus Services SA
F:39A
|
ES |
|
N
|
Namwiwat Medical Corp PCL
SET:NAM
|
TH |
Wall St Price Targets
ABUS Price Targets Summary
Arbutus Biopharma Corp
Arbutus Biopharma Corp
Wall Street analysts forecast ABUS stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ABUS is 5.61 USD with a low forecast of 5.555 USD and a high forecast of 5.775 USD.
Lowest Forecast
Price Target
5.555
USD
10% Upside
Average Forecast
Price Target
5.61
USD
11% Upside
Highest Forecast
Price Target
5.775
USD
14% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABUS's stock price target?
Price Target
5.61
USD
5.61
USD
According to Wall Street analysts, the average 1-year price target for ABUS is 5.61 USD with a low forecast of 5.555 USD and a high forecast of 5.775 USD.
What is the Revenue forecast for Arbutus Biopharma Corp?
Projected CAGR
-46%
-46%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 2 years is -46%.
